Health ❯ Diseases

Blood Disorders

Leukemia Sickle Cell Disease Thalassemia Thrombotic Thrombocytopenic Purpura Sickle-Cell Disease Aplastic Anaemia Sickle Cell Anemia HIV Aplastic Anemia Rare Diseases Chronic Myeloid Leukemia Myelodysplastic Syndrome Plasma Cell Disorders Anaemia Leukaemia HIV and Hepatitis C Myelodysplastic Syndromes Beta Thalassemia Hematopoietic Disorders Sickle-cell Disease Cancers Myelodysplastic Syndromes (MDS) Blood Clotting Chronic Lymphocytic Leukemia Lymphoma Hemophilia Diamond Blackfan Anaemia Myelofibrosis Polycythemia Vera Hepatitis Myelodysplasia

Fulcrum Halts Pociredir Development After FDA Flags PRC2 Cancer Risk

The FDA concluded PRC2-targeting therapies carry similar cancer risks, leaving no viable regulatory path for pociredir.

NYU Study Finds Highest Sickle Cell Death Risk and Costs on Long Island

Agios’ Sickle Cell Pill Lifts Hemoglobin but Misses Pain-Crisis Goal in Phase 3

Inflammatory Cells Rewire Bone Marrow Niche Early in CHIP and MDS, Study Finds

Major Study Finds Persistent Underuse and Disparities in Guideline-Recommended MDS Therapy